Literature DB >> 12242521

Immunohistochemical study of endocrine cells in ductal adenocarcinoma of the pancreas.

Mika Sakaki1, Toshiaki Sano, Mitsuyoshi Hirokawa, Masanori Takahashi, Hiroshi Kiyoku.   

Abstract

To clarify whether scattered endocrine cells in pancreatic ductal adenocarcinoma are neoplastic or not, we immunohistochemically studied 29 cases of invasive pancreatic ductal adenocarcinomas, 17 with metastases, for chromogranin A, insulin, glucagon, pancreatic polypeptide, serotonin, gastrin, laminin, and Ki-67. Endocrine cells were found in primary sites in 24 cases (82.3%), where endocrine cells showed at least a visibly close location to adjacent islet cells. Although endocrine cells in neoplastic glands were within the neoplastic basement membrane, endocrine cells were not seen in invasive sites beyond the pancreas where islets were not present. Endocrine cells in neoplastic glands were reactive for two or three of the islet hormones in all cases, and different types of hormonal reactivity was recognized in the same neoplastic gland or the same cluster of neoplastic glands in 22 (91.7%) cases, thus suggesting a close relation with islets. Ki-67 did not stain any endocrine cells in ten of the adenocarcinomas studied. In three (10.3%) cases, endocrine cells were found in the intraductal extensions. They may have pre-existed in non-neoplastic ducts. In 17 cases with metastatic sites, all but one had no endocrine cells in the metastases. Serotonin-positive cells were found in one metastatic lymph node in one case. We concluded that most endocrine cells seen in ductal adenocarcinomas of the pancreas are non-neoplastic and are derived from the surrounding islets. Some neoplastic endocrine cells may exist, though their frequency is low.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242521     DOI: 10.1007/s00428-002-0652-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  6 in total

1.  Enteroendocrine Cell Formation Is an Early Event in Pancreatic Tumorigenesis.

Authors:  Leah R Caplan; Vera Vavinskaya; David G Gelikman; Nidhi Jyotsana; Vincent Q Trinh; Kenneth P Olive; Marcus C B Tan; Kathleen E DelGiorno
Journal:  Front Physiol       Date:  2022-04-27       Impact factor: 4.755

2.  Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.

Authors:  N Ohike; A Jürgensen; M Pipeleers-Marichal; G Klöppel
Journal:  Virchows Arch       Date:  2003-02-06       Impact factor: 4.064

3.  Neoplastic endocrine differentiation of pancreatic ductal adenocarcinoma in a metastatic lymph node: report of a case.

Authors:  Tomotaka Akatsu; Kaori Kameyama; Yuki Nogami; Shigeyuki Kawachi; Masaki Kitajima; Yuko Kitagawa
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

4.  Advanced gastric neuroendocrine carcinoma with an adenocarcinoma component.

Authors:  Masashi Miguchi; Masahiko Iseki; Kunihiko Shimatani
Journal:  Case Rep Gastroenterol       Date:  2012-01-25

5.  Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors.

Authors:  Alexandra E Butler; Martha Campbell-Thompson; Tatyana Gurlo; David W Dawson; Mark Atkinson; Peter C Butler
Journal:  Diabetes       Date:  2013-03-22       Impact factor: 9.461

6.  Tumor-insular Complex in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma Is Associated With Higher Residual Tumor.

Authors:  Iván A González; Liang-I Kang; Gregory A Williams; Jingxia Liu; David G DeNardo; William G Hawkins; Deyali Chatterjee
Journal:  Am J Surg Pathol       Date:  2020-06       Impact factor: 6.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.